10x Genomics
$88.76Change from previous close: −1.77%Absolute change: −$1.60
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $11.56B
- Enterprise value
- $11.09B
- Forward P/E
- 1,157.7
- Price/book
- 14.0
- Price/sales
- 18.7
- EV/EBITDA
- -269.2
- EV/revenue
- 18.0
Profitability and growth
- Gross margin
- 70.1%
- Operating margin
- -15.2%
- Net margin
- -12.2%
- ROE
- -9.4%
- ROA
- -5.0%
- Revenue growth (year over year)
- -12.7%
Financial health
- Total cash
- $552.03M
- Total debt
- $78.8M
- Debt/equity
- 0.10
- Current ratio
- 5.69
- Quick ratio
- 5.09
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $62.13
- Median price target
- $60.00
- High price target
- $90.00
- Low price target
- $40.00
- Analysts with a price target
- 15
- Consensus
- Buy
- Forward EPS
- $0.08
- EPS estimate, current year
- $0.04
Shares and trading
- Beta
- 2.08
- Average volume
- 3.02M
- Shares outstanding
- 120.21M
- Float
- 118.19M
- Institutional ownership
- 120.3%
- Insider ownership
- 1.5%
- Short interest (% of float)
- 18.8%
- Short ratio (days)
- 6.17